nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Tiotropium—SLC22A4—rheumatoid arthritis	0.054	0.656	CrCbGaD
Methylscopolamine bromide—Ageusia—Penicillamine—rheumatoid arthritis	0.0292	0.0654	CcSEcCtD
Methylscopolamine bromide—Ipratropium bromide—SLC22A4—rheumatoid arthritis	0.0284	0.344	CrCbGaD
Methylscopolamine bromide—Mydriasis—Prednisolone—rheumatoid arthritis	0.0102	0.0229	CcSEcCtD
Methylscopolamine bromide—Constipation—Ergocalciferol—rheumatoid arthritis	0.0096	0.0215	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ergocalciferol—rheumatoid arthritis	0.00805	0.018	CcSEcCtD
Methylscopolamine bromide—Constipation—Auranofin—rheumatoid arthritis	0.00782	0.0175	CcSEcCtD
Methylscopolamine bromide—Urticaria—Auranofin—rheumatoid arthritis	0.00727	0.0163	CcSEcCtD
Methylscopolamine bromide—Urticaria—Penicillamine—rheumatoid arthritis	0.00671	0.015	CcSEcCtD
Methylscopolamine bromide—Nausea—Ergocalciferol—rheumatoid arthritis	0.00667	0.0149	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.00622	0.0139	CcSEcCtD
Methylscopolamine bromide—Vomiting—Auranofin—rheumatoid arthritis	0.00582	0.013	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Cyclosporine—rheumatoid arthritis	0.00567	0.0127	CcSEcCtD
Methylscopolamine bromide—Nausea—Auranofin—rheumatoid arthritis	0.00543	0.0122	CcSEcCtD
Methylscopolamine bromide—Vomiting—Penicillamine—rheumatoid arthritis	0.00537	0.012	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisolone—rheumatoid arthritis	0.00516	0.0116	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Hydrocortisone—rheumatoid arthritis	0.00504	0.0113	CcSEcCtD
Methylscopolamine bromide—Nausea—Penicillamine—rheumatoid arthritis	0.00502	0.0112	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Leflunomide—rheumatoid arthritis	0.0048	0.0107	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Triamcinolone—rheumatoid arthritis	0.00475	0.0106	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Methylprednisolone—rheumatoid arthritis	0.00474	0.0106	CcSEcCtD
Methylscopolamine bromide—Palpitations—Leflunomide—rheumatoid arthritis	0.0045	0.0101	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Leflunomide—rheumatoid arthritis	0.00424	0.00948	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Leflunomide—rheumatoid arthritis	0.00415	0.00929	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Leflunomide—rheumatoid arthritis	0.00405	0.00907	CcSEcCtD
Methylscopolamine bromide—Tension—Cyclosporine—rheumatoid arthritis	0.00385	0.00862	CcSEcCtD
Methylscopolamine bromide—Nervousness—Cyclosporine—rheumatoid arthritis	0.00381	0.00853	CcSEcCtD
Methylscopolamine bromide—Insomnia—Leflunomide—rheumatoid arthritis	0.00376	0.0084	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisone—rheumatoid arthritis	0.00375	0.0084	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Cyclosporine—rheumatoid arthritis	0.0037	0.00828	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.00362	0.00811	CcSEcCtD
Methylscopolamine bromide—Constipation—Leflunomide—rheumatoid arthritis	0.00355	0.00795	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Prednisone—rheumatoid arthritis	0.00343	0.00768	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.00342	0.00766	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisolone—rheumatoid arthritis	0.00337	0.00754	CcSEcCtD
Methylscopolamine bromide—Urticaria—Leflunomide—rheumatoid arthritis	0.0033	0.00738	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Cyclosporine—rheumatoid arthritis	0.00327	0.00732	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.00324	0.00725	CcSEcCtD
Methylscopolamine bromide—Confusional state—Cyclosporine—rheumatoid arthritis	0.00323	0.00723	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.00321	0.00717	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00306	0.00685	CcSEcCtD
Methylscopolamine bromide—Asthenia—Leflunomide—rheumatoid arthritis	0.00298	0.00667	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.00292	0.00653	CcSEcCtD
Methylscopolamine bromide—Dizziness—Azathioprine—rheumatoid arthritis	0.00291	0.00651	CcSEcCtD
Methylscopolamine bromide—Insomnia—Cyclosporine—rheumatoid arthritis	0.0029	0.00649	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Methotrexate—rheumatoid arthritis	0.00287	0.00642	CcSEcCtD
Methylscopolamine bromide—Somnolence—Cyclosporine—rheumatoid arthritis	0.00285	0.00638	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.00285	0.00637	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisolone—rheumatoid arthritis	0.00285	0.00637	CcSEcCtD
Methylscopolamine bromide—Vomiting—Azathioprine—rheumatoid arthritis	0.0028	0.00626	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.00278	0.00622	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methotrexate—rheumatoid arthritis	0.00278	0.00621	CcSEcCtD
Methylscopolamine bromide—Headache—Azathioprine—rheumatoid arthritis	0.00275	0.00616	CcSEcCtD
Methylscopolamine bromide—Dizziness—Leflunomide—rheumatoid arthritis	0.00275	0.00614	CcSEcCtD
Methylscopolamine bromide—Constipation—Cyclosporine—rheumatoid arthritis	0.00274	0.00613	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Triamcinolone—rheumatoid arthritis	0.00274	0.00612	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methylprednisolone—rheumatoid arthritis	0.0027	0.00604	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.00268	0.006	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.00268	0.00599	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.00264	0.00591	CcSEcCtD
Methylscopolamine bromide—Vomiting—Leflunomide—rheumatoid arthritis	0.00264	0.00591	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisolone—rheumatoid arthritis	0.00264	0.0059	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Triamcinolone—rheumatoid arthritis	0.00262	0.00586	CcSEcCtD
Methylscopolamine bromide—Nausea—Azathioprine—rheumatoid arthritis	0.00261	0.00584	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00261	0.00584	CcSEcCtD
Methylscopolamine bromide—Headache—Leflunomide—rheumatoid arthritis	0.0026	0.00582	CcSEcCtD
Methylscopolamine bromide—Insomnia—Hydrocortisone—rheumatoid arthritis	0.00258	0.00576	CcSEcCtD
Methylscopolamine bromide—Urticaria—Cyclosporine—rheumatoid arthritis	0.00255	0.0057	CcSEcCtD
Methylscopolamine bromide—Nausea—Leflunomide—rheumatoid arthritis	0.00247	0.00552	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisone—rheumatoid arthritis	0.00245	0.00548	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.00243	0.00545	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.00243	0.00545	CcSEcCtD
Methylscopolamine bromide—Insomnia—Triamcinolone—rheumatoid arthritis	0.00243	0.00543	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methylprednisolone—rheumatoid arthritis	0.00242	0.00542	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.0024	0.00538	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dexamethasone—rheumatoid arthritis	0.00238	0.00531	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betamethasone—rheumatoid arthritis	0.00238	0.00531	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00236	0.00528	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.00235	0.00525	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisolone—rheumatoid arthritis	0.00232	0.00518	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cyclosporine—rheumatoid arthritis	0.0023	0.00515	CcSEcCtD
Methylscopolamine bromide—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00226	0.00506	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.00221	0.00495	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.00221	0.00493	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betamethasone—rheumatoid arthritis	0.0022	0.00493	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dexamethasone—rheumatoid arthritis	0.0022	0.00493	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00215	0.00481	CcSEcCtD
Methylscopolamine bromide—Urticaria—Triamcinolone—rheumatoid arthritis	0.00213	0.00477	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methylprednisolone—rheumatoid arthritis	0.00213	0.00476	CcSEcCtD
Methylscopolamine bromide—Dizziness—Cyclosporine—rheumatoid arthritis	0.00212	0.00474	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.00212	0.00474	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.0021	0.0047	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisone—rheumatoid arthritis	0.00207	0.00463	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Methotrexate—rheumatoid arthritis	0.00205	0.00458	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydrocortisone—rheumatoid arthritis	0.00204	0.00457	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cyclosporine—rheumatoid arthritis	0.00204	0.00456	CcSEcCtD
Methylscopolamine bromide—Headache—Cyclosporine—rheumatoid arthritis	0.00201	0.00449	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.00201	0.00449	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.00201	0.00449	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00198	0.00442	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00197	0.00441	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dexamethasone—rheumatoid arthritis	0.00193	0.00433	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betamethasone—rheumatoid arthritis	0.00193	0.00433	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisolone—rheumatoid arthritis	0.00193	0.00432	CcSEcCtD
Methylscopolamine bromide—Asthenia—Triamcinolone—rheumatoid arthritis	0.00192	0.00431	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methylprednisolone—rheumatoid arthritis	0.00192	0.0043	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisone—rheumatoid arthritis	0.00192	0.00429	CcSEcCtD
Methylscopolamine bromide—Nausea—Cyclosporine—rheumatoid arthritis	0.0019	0.00426	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00188	0.00421	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisolone—rheumatoid arthritis	0.00183	0.00409	CcSEcCtD
Methylscopolamine bromide—Constipation—Prednisone—rheumatoid arthritis	0.00181	0.00406	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00181	0.00405	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methotrexate—rheumatoid arthritis	0.00179	0.004	CcSEcCtD
Methylscopolamine bromide—Headache—Hydrocortisone—rheumatoid arthritis	0.00178	0.00399	CcSEcCtD
Methylscopolamine bromide—Dizziness—Triamcinolone—rheumatoid arthritis	0.00177	0.00397	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.00177	0.00396	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00177	0.00396	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisone—rheumatoid arthritis	0.00175	0.00391	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betamethasone—rheumatoid arthritis	0.00175	0.00391	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dexamethasone—rheumatoid arthritis	0.00175	0.00391	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisolone—rheumatoid arthritis	0.00173	0.00388	CcSEcCtD
Methylscopolamine bromide—Vomiting—Triamcinolone—rheumatoid arthritis	0.00171	0.00382	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methylprednisolone—rheumatoid arthritis	0.0017	0.00381	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydrocortisone—rheumatoid arthritis	0.00169	0.00379	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisone—rheumatoid arthritis	0.00168	0.00377	CcSEcCtD
Methylscopolamine bromide—Headache—Triamcinolone—rheumatoid arthritis	0.00168	0.00376	CcSEcCtD
Methylscopolamine bromide—Headache—Methylprednisolone—rheumatoid arthritis	0.00168	0.00375	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dexamethasone—rheumatoid arthritis	0.00161	0.0036	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betamethasone—rheumatoid arthritis	0.00161	0.0036	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methotrexate—rheumatoid arthritis	0.0016	0.00358	CcSEcCtD
Methylscopolamine bromide—Nausea—Triamcinolone—rheumatoid arthritis	0.00159	0.00356	CcSEcCtD
Methylscopolamine bromide—Nausea—Methylprednisolone—rheumatoid arthritis	0.00159	0.00356	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methotrexate—rheumatoid arthritis	0.00157	0.00352	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisone—rheumatoid arthritis	0.00156	0.00349	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dexamethasone—rheumatoid arthritis	0.00155	0.00346	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betamethasone—rheumatoid arthritis	0.00155	0.00346	CcSEcCtD
Methylscopolamine bromide—Headache—Dexamethasone—rheumatoid arthritis	0.00152	0.00341	CcSEcCtD
Methylscopolamine bromide—Headache—Betamethasone—rheumatoid arthritis	0.00152	0.00341	CcSEcCtD
Methylscopolamine bromide—Asthenia—Prednisone—rheumatoid arthritis	0.00152	0.0034	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.00146	0.00327	CcSEcCtD
Methylscopolamine bromide—Nausea—Dexamethasone—rheumatoid arthritis	0.00145	0.00323	CcSEcCtD
Methylscopolamine bromide—Nausea—Betamethasone—rheumatoid arthritis	0.00145	0.00323	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methotrexate—rheumatoid arthritis	0.00141	0.00315	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisone—rheumatoid arthritis	0.0014	0.00314	CcSEcCtD
Methylscopolamine bromide—Vomiting—Prednisone—rheumatoid arthritis	0.00135	0.00302	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisone—rheumatoid arthritis	0.00133	0.00297	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.0013	0.00292	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methotrexate—rheumatoid arthritis	0.00127	0.00284	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisone—rheumatoid arthritis	0.00126	0.00282	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methotrexate—rheumatoid arthritis	0.00117	0.00262	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methotrexate—rheumatoid arthritis	0.00113	0.00252	CcSEcCtD
Methylscopolamine bromide—Headache—Methotrexate—rheumatoid arthritis	0.00111	0.00248	CcSEcCtD
Methylscopolamine bromide—Nausea—Methotrexate—rheumatoid arthritis	0.00105	0.00235	CcSEcCtD
Methylscopolamine bromide—CHRM3—Signaling Pathways—C5—rheumatoid arthritis	0.00026	0.000553	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.00026	0.000553	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.00026	0.000552	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MMP3—rheumatoid arthritis	0.00026	0.000552	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.000259	0.00055	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—C5—rheumatoid arthritis	0.000258	0.000547	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000258	0.000547	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000257	0.000546	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000257	0.000546	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000256	0.000544	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ENO1—rheumatoid arthritis	0.000254	0.000539	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000254	0.000539	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000253	0.000537	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SYK—rheumatoid arthritis	0.000252	0.000535	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000247	0.000526	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—POMC—rheumatoid arthritis	0.000246	0.000522	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000246	0.000522	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR6—rheumatoid arthritis	0.000245	0.000521	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000245	0.000521	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR6—rheumatoid arthritis	0.000245	0.00052	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000244	0.000518	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000243	0.000516	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT1—rheumatoid arthritis	0.000243	0.000516	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000243	0.000516	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR6—rheumatoid arthritis	0.000242	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000242	0.000514	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000241	0.000513	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000241	0.000511	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000241	0.000511	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.00024	0.000511	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6R—rheumatoid arthritis	0.00024	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL10—rheumatoid arthritis	0.00024	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.00024	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000239	0.000508	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NCF2—rheumatoid arthritis	0.000239	0.000507	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—C3—rheumatoid arthritis	0.000238	0.000506	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NCF2—rheumatoid arthritis	0.000238	0.000506	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—C3—rheumatoid arthritis	0.000238	0.000505	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000237	0.000504	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NCF2—rheumatoid arthritis	0.000236	0.000501	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—C3—rheumatoid arthritis	0.000235	0.0005	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000233	0.000494	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000233	0.000494	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000232	0.000493	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000232	0.000493	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GZMB—rheumatoid arthritis	0.000231	0.000491	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GZMB—rheumatoid arthritis	0.00023	0.00049	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SH2B3—rheumatoid arthritis	0.00023	0.000488	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TRAF6—rheumatoid arthritis	0.00023	0.000488	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GZMB—rheumatoid arthritis	0.000228	0.000485	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000224	0.000477	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL3—rheumatoid arthritis	0.000224	0.000477	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000224	0.000475	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL3—rheumatoid arthritis	0.000224	0.000475	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000222	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL3—rheumatoid arthritis	0.000222	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000221	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000221	0.000469	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SAA1—rheumatoid arthritis	0.00022	0.000466	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SAA1—rheumatoid arthritis	0.000219	0.000465	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000219	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP3—rheumatoid arthritis	0.000219	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000218	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000218	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000218	0.000462	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SAA1—rheumatoid arthritis	0.000217	0.00046	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—C3—rheumatoid arthritis	0.000216	0.00046	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—C3—rheumatoid arthritis	0.000216	0.000458	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000215	0.000458	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000215	0.000457	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NCF1—rheumatoid arthritis	0.000214	0.000455	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—C3—rheumatoid arthritis	0.000214	0.000454	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NCF1—rheumatoid arthritis	0.000212	0.000451	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTK2—rheumatoid arthritis	0.00021	0.000447	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000209	0.000445	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CD28—rheumatoid arthritis	0.000207	0.000439	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL5—rheumatoid arthritis	0.000206	0.000438	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CD28—rheumatoid arthritis	0.000206	0.000438	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CD28—rheumatoid arthritis	0.000204	0.000434	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CSF2—rheumatoid arthritis	0.000203	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—IL2—rheumatoid arthritis	0.0002	0.000425	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000195	0.000414	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000194	0.000412	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000192	0.000408	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SPP1—rheumatoid arthritis	0.000191	0.000406	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000191	0.000406	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000191	0.000406	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000191	0.000405	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL12—rheumatoid arthritis	0.00019	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.00019	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.00019	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—POMC—rheumatoid arthritis	0.00019	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000189	0.000402	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000189	0.000401	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000189	0.000401	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000188	0.0004	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000188	0.0004	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000188	0.0004	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000188	0.0004	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000187	0.000397	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000186	0.000396	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR5—rheumatoid arthritis	0.000186	0.000395	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000183	0.000389	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAT—rheumatoid arthritis	0.000183	0.000388	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL2—rheumatoid arthritis	0.000182	0.000386	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—C3—rheumatoid arthritis	0.000182	0.000386	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000178	0.000378	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SYK—rheumatoid arthritis	0.000177	0.000377	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000177	0.000377	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SYK—rheumatoid arthritis	0.000177	0.000376	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000176	0.000373	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SYK—rheumatoid arthritis	0.000175	0.000372	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000174	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000174	0.000369	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000173	0.000368	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—POMC—rheumatoid arthritis	0.000173	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000172	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT1—rheumatoid arthritis	0.000171	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—POMC—rheumatoid arthritis	0.000171	0.000363	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT1—rheumatoid arthritis	0.000171	0.000362	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000169	0.00036	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LEP—rheumatoid arthritis	0.000169	0.000359	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT1—rheumatoid arthritis	0.000169	0.000359	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000169	0.000359	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000169	0.000359	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000169	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000168	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000168	0.000357	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000167	0.000355	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000167	0.000354	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000167	0.000354	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FN1—rheumatoid arthritis	0.000159	0.000339	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000159	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP3—rheumatoid arthritis	0.000154	0.000327	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000154	0.000327	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP3—rheumatoid arthritis	0.000153	0.000326	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000153	0.000326	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CD80—rheumatoid arthritis	0.000153	0.000325	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—rheumatoid arthritis	0.000152	0.000324	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP3—rheumatoid arthritis	0.000152	0.000323	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000152	0.000323	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000148	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTK2—rheumatoid arthritis	0.000148	0.000314	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000147	0.000313	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000147	0.000312	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTK2—rheumatoid arthritis	0.000146	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000146	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—rheumatoid arthritis	0.000145	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—rheumatoid arthritis	0.000145	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—rheumatoid arthritis	0.000145	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—rheumatoid arthritis	0.000143	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000143	0.000304	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CSF2—rheumatoid arthritis	0.000143	0.000303	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—rheumatoid arthritis	0.000142	0.000302	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6R—rheumatoid arthritis	0.000142	0.000301	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CSF2—rheumatoid arthritis	0.000141	0.0003	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000141	0.000299	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2—rheumatoid arthritis	0.00014	0.000298	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000139	0.000296	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000134	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—rheumatoid arthritis	0.000134	0.000285	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000134	0.000284	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000133	0.000284	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—rheumatoid arthritis	0.000133	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000132	0.000281	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR5—rheumatoid arthritis	0.000131	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR5—rheumatoid arthritis	0.00013	0.000277	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR5—rheumatoid arthritis	0.000129	0.000274	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TYK2—rheumatoid arthritis	0.000129	0.000274	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000129	0.000274	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000129	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—rheumatoid arthritis	0.000128	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—C3—rheumatoid arthritis	0.000128	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—rheumatoid arthritis	0.000128	0.000271	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—C3—rheumatoid arthritis	0.000127	0.000271	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000127	0.00027	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—rheumatoid arthritis	0.000127	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—rheumatoid arthritis	0.000126	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—C3—rheumatoid arthritis	0.000126	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—rheumatoid arthritis	0.000122	0.000259	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—rheumatoid arthritis	0.000119	0.000253	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—rheumatoid arthritis	0.000119	0.000252	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—rheumatoid arthritis	0.000117	0.00025	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—rheumatoid arthritis	0.000112	0.000239	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FN1—rheumatoid arthritis	0.000112	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FN1—rheumatoid arthritis	0.000112	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000112	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000111	0.000237	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—rheumatoid arthritis	0.000111	0.000236	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FN1—rheumatoid arthritis	0.000111	0.000235	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6ST—rheumatoid arthritis	0.00011	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CD80—rheumatoid arthritis	0.000108	0.000229	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—rheumatoid arthritis	0.000107	0.000228	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CD80—rheumatoid arthritis	0.000107	0.000228	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—rheumatoid arthritis	0.000107	0.000227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—rheumatoid arthritis	0.000106	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CD80—rheumatoid arthritis	0.000106	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	0.000102	0.000217	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	0.000102	0.000217	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	0.000102	0.000216	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	0.000101	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	0.000101	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	0.0001	0.000213	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	9.97e-05	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	9.97e-05	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	9.94e-05	0.000211	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	9.88e-05	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	9.87e-05	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	9.85e-05	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	9.72e-05	0.000207	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	9.12e-05	0.000194	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	9.08e-05	0.000193	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	9.05e-05	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	8.97e-05	0.000191	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	8.92e-05	0.000189	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	8.89e-05	0.000189	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	8.8e-05	0.000187	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	8.37e-05	0.000178	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	7.91e-05	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	7.88e-05	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	7.81e-05	0.000166	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	7.56e-05	0.000161	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	7.53e-05	0.00016	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	7.52e-05	0.00016	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	7.5e-05	0.000159	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	7.46e-05	0.000159	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	7.42e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	7.15e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	7.13e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	7.08e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	7.06e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	7.06e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	6.99e-05	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	6.96e-05	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	6.93e-05	0.000147	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	6.89e-05	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	6.87e-05	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	6.42e-05	0.000136	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	6.4e-05	0.000136	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	6.34e-05	0.000135	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	6.31e-05	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	5.9e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	5.88e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	5.82e-05	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	4.85e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	4.84e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	4.79e-05	0.000102	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	4.44e-05	9.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	4.43e-05	9.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	4.39e-05	9.32e-05	CbGpPWpGaD
